Form 4: Progyny Inc. President Michael E. Sturmer Sells 9,030 Shares
SEC Form 4 Filing
Michael E. Sturmer, President of Progyny, Inc., sold 9,030 shares of common stock at $30 per share on July 16, 2024, according to a Form 4 filing with the SEC.
Summary
- On July 16, 2024, Michael E. Sturmer, President of Progyny, Inc. (PGNY), sold 9,030 shares of the company's common stock.
- The sale was executed at a price of $30 per share.
- Following the transaction, Sturmer directly owns 362,583 shares of Progyny, Inc.
- The sale was conducted under a Rule 10b5-1 trading plan established on August 31, 2023.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock sale under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although sales under 10b5-1 plans are generally viewed as less concerning.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are designed to allow insiders to sell shares without being accused of trading on non-public information.
Stakeholder Impact
- The sale could have a minor impact on shareholder sentiment, depending on how it's perceived by the market.
Key Dates
| Date | Description |
|---|---|
| August 31, 2023 | Date of establishment of the Rule 10b5-1 trading plan. |
| July 16, 2024 | Date of the stock sale transaction. |
| July 18, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.